Challenges and Strategies for Topical and Transdermal Delivery of Bioactive Peptides.


Journal

Critical reviews in therapeutic drug carrier systems
ISSN: 2162-660X
Titre abrégé: Crit Rev Ther Drug Carrier Syst
Pays: United States
ID NLM: 8511159

Informations de publication

Date de publication:
2022
Historique:
entrez: 22 12 2021
pubmed: 23 12 2021
medline: 25 12 2021
Statut: ppublish

Résumé

Bioactive peptides have gained the attention and interest of researchers and the industry for their therapeutic effects and high specificity, thus reducing the risks of side effects and making them an attractive alternatives in developing new biopharmaceuticals or cosmeceuticals. Nevertheless, their incorporation into formulations and administration presents challenges such as low stability under different storage conditions and gastrointestinal degradation after oral delivery. Likewise, the parenteral route is an invasive method that is painful and therefore reduces patient compliance. Topical delivery of bioactive peptides is a painless noninvasive alternative to reduce peptide degradation, exert local effects in the applied area, and improve patient compliance. In this review, we discuss the physicochemical properties of peptides and the mechanisms involved in their degradation. In addition, the most important aspects of skin structure and skin permeation routes, and the requirements for topical and transdermal drug delivery are also discussed in this article. Finally, nanocarrier development advances for the topical delivery of peptides (water-in-oil-in-water emulsions, microemulsions, nanoparticles, solid lipid nanoparticles, liposomes, niosomes, and microneedles) and other strategies, such as metal complexation, cell-penetrating peptides, and synthetic modification, are also reviewed. All these topics consider the perspective of their effect to improve skin permeability to peptides and their stability over time during storage.

Identifiants

pubmed: 34936316
pii: 6ed0f7a902a1b2f0,08cc8a443e810f96
doi: 10.1615/CritRevTherDrugCarrierSyst.2021038141
doi:

Substances chimiques

Cell-Penetrating Peptides 0
Lipid Nanoparticles 0
Liposomes 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-31

Auteurs

Antonio Jiménez-Rodríguez (A)

Tecnológico de Monterrey, Centro de Biotecnología FEMSA, Escuela de Ingeniería y Ciencias, Monterrey, Nuevo Léon, Mexico.

Daniela Guardado-Félix (D)

Tecnológico de Monterrey, Centro de Biotecnología FEMSA, Escuela de Ingeniería y Ciencias, Monterrey, Nuevo Léon, Mexico; Programa Regional de Posgrado en Biotecnología, Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Sinaloa, Facultad de Ciencias Químico Biológicas (FCQB-UAS), Culiacán, Sinaloa, Mexico.

Marilena Antunes-Ricardo (M)

Tecnológico de Monterrey, Centro de Biotecnología FEMSA, Escuela de Ingeniería y Ciencias, Monterrey, Nuevo Léon, Mexico.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH